scutellarin has been researched along with Diabetic Cardiomyopathies in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, X; Qi, F; Wu, W | 1 |
| Fan, X; Li, S; Li, Z; Su, Y; Tian, M | 1 |
| Chen, R; Ma, X; Sun, G; Sun, X; Xu, L; Zhang, X; Zhu, Y | 1 |
3 other study(ies) available for scutellarin and Diabetic Cardiomyopathies
| Article | Year |
|---|---|
Effect of intervention in the diacylglycerol‑protein kinase C signaling pathway on JNK1 expression and its downstream signaling in diabetic cardiomyopathy.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Diglycerides; Disease Models, Animal; Flavonoids; Gene Expression Regulation; Insulin Receptor Substrate Proteins; Mitogen-Activated Protein Kinase 8; Myocardium; Protein Kinase C; Protein Kinase C beta; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction; TOR Serine-Threonine Kinases | 2014 |
Scutellarin Improves Type 2 Diabetic Cardiomyopathy by Regulating Cardiomyocyte Autophagy and Apoptosis.
Topics: Apigenin; Apoptosis; Autophagy; Diabetes Mellitus, Type 2; Diabetic Cardiomyopathies; Glucuronates; Humans; Myocytes, Cardiac; RNA, Messenger | 2022 |
Scutellarin protects against diabetic cardiomyopathy via inhibiting oxidative stress and inflammatory response in mice.
Topics: Animals; Apigenin; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Glucuronates; Mice; Mice, Inbred C57BL; Oxidative Stress | 2021 |